Issues surrounding efforts to prevent youth access to tobacco products. Implementation of P.L. 111-31, the Tobacco Control Act, and issues related to FDA Premarket Tobacco Product Application (PMTA). Outreach related to Notice of Proposed Rulemaking for Docket Nos. FDA-2021-N-1349 (Tobacco Product Standard for Menthol in Cigarettes) and FDA-2021-N-1309 (Tobacco Product Standard for Characterizing Flavors in Cigars). Outreach related to Notice of Proposed Rulemaking for RIN: 0910-AI76 (Tobacco Product Standard for Nicotine Level of Certain Tobacco Products).
H.R. 4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024, provisions related to Tobacco Product Standard for Menthol in Cigarettes, Tobacco Product Standard for Characterizing Flavors in Cigars, and Tobacco Product Standard for Nicotine Level of Certain Tobacco Products.
H.R. 5715/S. 2929, Tobacco Tax Equity Act, provisions related to taxation of tobacco products. H.R. 5568/S. 2846, CARE for Moms Act, provisions related to taxation of tobacco products.
Duration: April 1, 2022
to
present
General Issues: Tobacco , Budget/Appropriations , Taxation/Internal Revenue Code , Trade (Domestic & Foreign)
Spending: about $750,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2022: U.S. Senate, House of Representatives, Office of Management & Budget (OMB)
Related Foreign Entities:
JTI (UK) Management Ltd. (Weybridge, Surrey, GBR); contribution to lobbying: $0; ownership 100%; JT International Holding B.V. (Amstelveen, NED); contribution to lobbying: $0; ownership 100%; JT International Group Holding B.V. (Amstelveen, NED); contribution to lobbying: $0; ownership 100%; Japan Tobacco Inc. (Tokyo, JPN); contribution to lobbying: $0; ownership 100%
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Japan Tobacco International U.S.A., Inc. had in-house lobbyists. The report was filed on April 22.
Original Filing: 301569869.xml
Lobbying Issues
Issues surrounding efforts to prevent youth access to tobacco products. Implementation of P.L. 111-31, the Tobacco Control Act, and issues related to FDA Premarket Tobacco Product Application (PMTA). Outreach related to Notice of Proposed Rulemaking for Docket Nos. FDA-2021-N-1349 (Tobacco Product Standard for Menthol in Cigarettes) and FDA-2021-N-1309 (Tobacco Product Standard for Characterizing Flavors in Cigars). Outreach related to Notice of Proposed Rulemaking for RIN: 0910-AI76 (Tobacco Product Standard for Nicotine Level of Certain Tobacco Products).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
Lobbying Issues
H.R. 4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024, provisions related to Tobacco Product Standard for Menthol in Cigarettes, Tobacco Product Standard for Characterizing Flavors in Cigars, and Tobacco Product Standard for Nicotine Level of Certain Tobacco Products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 5715/S. 2929, Tobacco Tax Equity Act, provisions related to taxation of tobacco products. H.R. 5568/S. 2846, CARE for Moms Act, provisions related to taxation of tobacco products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2023
In Q4, Japan Tobacco International U.S.A., Inc. had in-house lobbyists. The report was filed on Jan. 19.
Original Filing: 301529358.xml
Lobbying Issues
Issues surrounding efforts to prevent youth access to tobacco products. Implementation of P.L. 111-31, the Tobacco Control Act, and issues related to FDA Premarket Tobacco Product Application (PMTA). Outreach related to Notice of Proposed Rulemaking for Docket Nos. FDA-2021-N-1349 (Tobacco Product Standard for Menthol in Cigarettes) and FDA-2021-N-1309 (Tobacco Product Standard for Characterizing Flavors in Cigars). Outreach related to Notice of Proposed Rulemaking for RIN: 0910-AI76 (Tobacco Product Standard for Nicotine Level of Certain Tobacco Products).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024, provisions related to Tobacco Product Standard for Menthol in Cigarettes, Tobacco Product Standard for Characterizing Flavors in Cigars, and Tobacco Product Standard for Nicotine Level of Certain Tobacco Products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 5715/S. 2929, Tobacco Tax Equity Act, provisions related to taxation of tobacco products. H.R. 5568/S. 2846, CARE for Moms Act, provisions related to taxation of tobacco products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2023
In Q3, Japan Tobacco International U.S.A., Inc. had in-house lobbyists. The report was filed on Oct. 20, 2023.
Original Filing: 301513144.xml
Lobbying Issues
Issues surrounding efforts to prevent youth access to tobacco products. Implementation of P.L. 111-31, the Tobacco Control Act, and issues related to FDA Premarket Tobacco Product Application (PMTA). Outreach related to Notice of Proposed Rulemaking for Docket Nos. FDA-2021-N-1349 (Tobacco Product Standard for Menthol in Cigarettes) and FDA-2021-N-1309 (Tobacco Product Standard for Characterizing Flavors in Cigars). Outreach related to Notice of Proposed Rulemaking for RIN: 0910-AI76 (Tobacco Product Standard for Nicotine Level of Certain Tobacco Products).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024, provisions related to Tobacco Product Standard for Menthol in Cigarettes, Tobacco Product Standard for Characterizing Flavors in Cigars, and Tobacco Product Standard for Nicotine Level of Certain Tobacco Products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 5715/S. 2929, Tobacco Tax Equity Act, provisions related to taxation of tobacco products. H.R. 5568/S. 2846, provisions related to taxation of tobacco products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2023
In Q2, Japan Tobacco International U.S.A., Inc. had in-house lobbyists. The report was filed on July 20, 2023.
Original Filing: 301490253.xml
Lobbying Issues
Issues surrounding efforts to prevent youth access to tobacco products. Implementation of P.L. 111-31, the Tobacco Control Act, and issues related to FDA Premarket Tobacco Product Application (PMTA). Outreach related to Notice of Proposed Rulemaking for Docket Nos. FDA-2021-N-1349 (Tobacco Product Standard for Menthol in Cigarettes) and FDA-2021-N-1309 (Tobacco Product Standard for Characterizing Flavors in Cigars). Outreach related to Notice of Proposed Rulemaking for RIN: 0910-AI76 (Tobacco Product Standard for Nicotine Level of Certain Tobacco Products).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R.4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024, provisions related to Tobacco Product Standard for Menthol in Cigarettes, Tobacco Product Standard for Characterizing Flavors in Cigars, and Tobacco Product Standard for Nicotine Level of Certain Tobacco Products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, Japan Tobacco International U.S.A., Inc. had in-house lobbyists. The report was filed on April 19, 2023.
Original Filing: 301456821.xml
Lobbying Issues
Issues surrounding efforts to prevent youth access to tobacco products. Implementation of P.L. 111-31, the Tobacco Control Act, and issues related to FDA Premarket Tobacco Product Application (PMTA). Outreach related to Notice of Proposed Rulemaking for Docket Nos. FDA-2021-N-1349 (Tobacco Product Standard for Menthol in Cigarettes) and FDA-2021-N-1309 (Tobacco Product Standard for Characterizing Flavors in Cigars). Outreach related to Notice of Proposed Rulemaking for RIN: 0910-AI76 (Tobacco Product Standard for Nicotine Level of Certain Tobacco Products).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, Japan Tobacco International U.S.A., Inc. had in-house lobbyists. The report was filed on Jan. 20, 2023.
Original Filing: 301438447.xml
Lobbying Issues
Issues surrounding efforts to prevent youth access to tobacco products.
Issues related to the regulation of synthetic nicotine products not derived from tobacco.
Implementation of P.L. 111-31, the Tobacco Control Act, and issues related to FDA Premarket Tobacco Product Application (PMTA).
Outreach related to Notice of Proposed Rulemaking for Docket Nos. FDA-2021-N-1349 (Tobacco Product Standard for Menthol in Cigarettes) and FDA-2021-N-1309 (Tobacco Product Standard for Characterizing Flavors in Cigars).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 2471, Consolidated Appropriations Act, 2022, provisions related to synthetic nicotine.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Outreach related to taxation of tobacco products.
S. 916/H.R. 1897, Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAS Act), provisions related to the taxation of tobacco products.
H.R. 5376 - Inflation Reduction Act, provisions related to the taxation of tobacco products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2022
In Q3, Japan Tobacco International U.S.A., Inc. had in-house lobbyists. The report was filed on Oct. 20, 2022.
Original Filing: 301418120.xml
Lobbying Issues
Issues surrounding efforts to prevent youth access to tobacco products.
Issues related to the regulation of synthetic nicotine products not derived from tobacco.
Implementation of P.L. 111-31, the Tobacco Control Act, and issues related to FDA Premarket Tobacco Product Application (PMTA).
Outreach related to Notice of Proposed Rulemaking for Docket Nos. FDA-2021-N-1349 (Tobacco Product Standard for Menthol in Cigarettes) and FDA-2021-N-1309 (Tobacco Product Standard for Characterizing Flavors in Cigars).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 2471, Consolidated Appropriations Act, 2022, provisions related to synthetic nicotine.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Outreach related to taxation of tobacco products.
S. 916/H.R. 1897, Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAS Act), provisions related to the taxation of tobacco products.
H.R. 5376 - Inflation Reduction Act, provisions related to the taxation of tobacco products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2022
In Q2, Japan Tobacco International U.S.A., Inc. had in-house lobbyists. The report was filed on July 18, 2022.
Original Filing: 301383730.xml
Lobbying Issues
Issues surrounding efforts to prevent youth access to tobacco products.
Issues related to the regulation of synthetic nicotine products not derived from tobacco.
Implementation of P.L. 111-31, the Tobacco Control Act, and issues related to FDA Premarket Tobacco Product Application (PMTA).
Outreach related to Notice of Proposed Rulemaking for Docket Nos. FDA-2021-N-1349 (Tobacco Product Standard for Menthol in Cigarettes) and FDA-2021-N-1309 (Tobacco Product Standard for Characterizing Flavors in Cigars).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 2471, Consolidated Appropriations Act, 2022, provisions related to synthetic nicotine.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Outreach related to taxation of tobacco products.
S. 916/H.R. 1897, Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAS Act), provisions related to the taxation of tobacco products.
H.R. 5376 - Build Back Better Act, provisions related to the taxation of tobacco products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2022
Japan Tobacco International U.S.A., Inc. filed a lobbying registration on May 4, 2022 for in-house lobbying efforts, effective April 1, 2022.
Original Filing: 301374076.xml
Issue(s) they said they’d lobby about: Address issues related to the manufacture and distribution of tobacco. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate